Quest Diagnostics (DGX) Operating Leases (2019 - 2026)

Quest Diagnostics has disclosed Operating Leases across 8 years of filings, most recently posting $561.0 million for Q2 2026.

• In Q2 2026, Operating Leases rose 3.89% year-over-year to $561.0 million; the TTM figure through Jun 2026 stood at $561.0 million (up 3.89% YoY), while the FY2025 annual figure was $537.0 million, down 25.93% from the prior year.
• Operating Leases came in at $561.0 million for Q2 2026 at Quest Diagnostics, down from $574.0 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $725.0 million in Q4 2024 to a low of $489.0 million in Q1 2024.
• Average Operating Leases over 5 years is $549.4 million, with a median of $535.5 million recorded in 2025.
• The largest YoY upside for Operating Leases was 10.02% in 2025 against a maximum downside of 25.93% in 2025.
• Over 5 years, Operating Leases stood at $651.0 million in 2022, then gained by 1.84% to $663.0 million in 2023, then grew by 9.35% to $725.0 million in 2024, then dropped by 25.93% to $537.0 million in 2025, then rose by 4.47% to $561.0 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $561.0 million in Q2 2026, $574.0 million in Q1 2026, and $537.0 million in Q4 2025.